Moberg Pharma Receives Favorable Outcome From NAD – Main Competitor to Discontinue Current Marketing

January 15, 2018

Responsive image

STOCKHOLM, Jan. 15, 2018 /PRNewswire/ –Moberg Pharma AB (OMX: MOB) have received a positive outcome from the NAD (National Advertising Division) regarding a challenge filed on Fungi-Nail, the largest U.S. competitor to the Kerasal Nail®product. NAD recommends the advertiser to…

Category: Precious Metals